
In April 2026, Central Drugs Laboratories identified 42 drug samples as not of standard quality (NSQ), while state drug testing labs found 127 such samples, according to the Union Health Ministry. One spurious drug sample from Bihar was also detected, allegedly produced by unauthorized manufacturers using another company's brand name. These findings are part of routine surveillance, with lists published monthly on the CDSCO portal. Investigations and legal actions are underway to remove substandard and spurious drugs from the market.
The articles present official information from the Union Health Ministry and related government laboratories without political commentary or partisan framing. Coverage focuses on regulatory actions and public health monitoring, reflecting a neutral governmental perspective. No opposition or alternative viewpoints are included, emphasizing factual reporting of drug quality surveillance.
The tone across the articles is neutral and factual, reporting government findings and ongoing investigations without emotive language. The coverage neither sensationalizes the issue nor downplays concerns, maintaining an informative and measured approach to public health updates.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| ndtv | 42 Drug Samples Found 'Not Of Standard Quality (NSQ)' In April: Health Ministry | Center | Neutral |
| news18 | 42 drug samples found 'not of standard quality (NSQ)' in April: Health Ministry | Center | Neutral |
news18 broke this story on 21 May, 01:58 pm. Other outlets followed.
Story is receiving appropriate media attention relative to public interest.
TBN's analysis identified the following accountability dimensions in this story.
This story involves a risk to public safety — infrastructure failure, regulatory lapse, hazardous conditions, or emergency mishandling.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.